Skip to main content
logo
Eli Lilly and Company (FRA:LLY)
Germany flag Germany · Delayed Price · Currency is EUR
873.10
+12.80 (1.49%)
At close: Jan 30, 2026

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Baqsimi Revenue
-29.10M
Basaglar Revenue
657.70M676.90M
Humalog Revenue
2.26B2.32B
Humulin Revenue
805.30M917.10M
Jardiance Revenue
3.86B3.34B
Mounjaro Revenue
19.09B11.54B
Trajenta Revenue
336.00M353.90M
Trulicity Revenue
4.49B5.25B
Zepbound Revenue
11.19B4.93B
Other Cardiometabolic Health Revenue
150.80M187.90M
Cardiometabolic Health Revenue
42.84B29.52B
Oncology Revenue
9.32B8.75B
Immunology Revenue
5.00B4.39B
Neuroscience Revenue
1.32B1.47B
Other Product Revenue
942.20M903.00M
Revenue (Other)
-11.19B-4.93B
Revenue (Total)
59.42B45.04B

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
US Revenue
39.64B30.38B
Europe Revenue
10.91B6.92B
Japan Revenue
2.04B1.81B
China Revenue
1.91B1.66B
Other Foreign Countries Revenue
4.93B4.27B
Revenue (Other)
100.00K100.00K
Revenue (Total)
59.42B45.04B

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Revenue Change due to Price
5.00%
Revenue Change due to Volume
27.00%
Updated Sep 30, 2025. Data Source: Fiscal.ai.